These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24860438)

  • 1. Attitudes toward pharmacological cognitive enhancement-a review.
    Schelle KJ; Faulmüller N; Caviola L; Hewstone M
    Front Syst Neurosci; 2014; 8():53. PubMed ID: 24860438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement.
    Maier LJ; Liakoni E; Schildmann J; Schaub MP; Liechti ME
    PLoS One; 2015; 10(12):e0144402. PubMed ID: 26657300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moral Attitudes Toward Pharmacological Cognitive Enhancement (PCE): Differences and Similarities Among Germans With and Without PCE Experience.
    Pohl S; Boelsen H; Hildt E
    Front Pharmacol; 2018; 9():1451. PubMed ID: 30618746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is Cognitive Enhancement Deemed Unacceptable? The Role of Fairness, Deservingness, and Hollow Achievements.
    Faber NS; Savulescu J; Douglas T
    Front Psychol; 2016; 7():232. PubMed ID: 26925027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Cognitive Enhancement in Greek University Students: Differences Between Users and Non-Users in Social Cognitive Variables, Burnout, and Engagement.
    Lazuras L; Ypsilanti A; Lamprou E; Kontogiorgis C
    Subst Use Misuse; 2017 Jun; 52(7):950-958. PubMed ID: 28426360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Students' Attitudes Towards Pharmacological Cognitive Enhancement With Methylphenidate.
    Erasmus N; Kotzé C
    Acad Psychiatry; 2020 Dec; 44(6):721-726. PubMed ID: 32974792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students.
    Maier LJ; Haug S; Schaub MP
    Drug Alcohol Depend; 2015 Nov; 156():221-227. PubMed ID: 26455555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Questionnaire Survey Concerning Pharmacological Cognitive Enhancement among Undergraduates].
    Yamamoto M; Ishii Y
    Yakugaku Zasshi; 2020; 140(11):1397-1403. PubMed ID: 33132276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities.
    Vagwala MK; Bicquelet A; Didziokaite G; Coomber R; Corrigan O; Singh I
    Neuroethics; 2017; 10(3):389-403. PubMed ID: 28890739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate.
    Maslen H; Faulmüller N; Savulescu J
    Front Syst Neurosci; 2014; 8():107. PubMed ID: 24999320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
    Schleim S; Quednow BB
    Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological Cognitive Enhancement: Current Situation and Perspectives].
    Yamamoto M
    Yakugaku Zasshi; 2022; 142(5):521-526. PubMed ID: 35491158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. True to oneself? Broad and narrow ideas on authenticity in the enhancement debate.
    Bolt LL
    Theor Med Bioeth; 2007; 28(4):285-300. PubMed ID: 17909988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland.
    Singh I; Bard I; Jackson J
    PLoS One; 2014; 9(10):e105969. PubMed ID: 25356917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroenhancing public health.
    Shaw D
    J Med Ethics; 2014 Jun; 40(6):389-91. PubMed ID: 23793059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pills or Push-Ups? Effectiveness and Public Perception of Pharmacological and Non-Pharmacological Cognitive Enhancement.
    Caviola L; Faber NS
    Front Psychol; 2015; 6():1852. PubMed ID: 26696922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review.
    Sharif S; Guirguis A; Fergus S; Schifano F
    Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33802176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Researchers' Ethical Concerns About Using Adaptive Deep Brain Stimulation for Enhancement.
    Kostick-Quenet K; Kalwani L; Koenig B; Torgerson L; Sanchez C; Munoz K; Hsu RL; Sierra-Mercado D; Robinson JO; Outram S; Pereira S; McGuire A; Zuk P; Lazaro-Munoz G
    Front Hum Neurosci; 2022; 16():813922. PubMed ID: 35496073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.
    Franke AG; Northoff R; Hildt E
    Pharmacopsychiatry; 2015 Nov; 48(7):256-64. PubMed ID: 26252723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
    Banjo OC; Nadler R; Reiner PB
    PLoS One; 2010 Dec; 5(12):e14322. PubMed ID: 21179461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.